FDA Okays Topiramate ER (Qudexy) Monotherapy in Children FDA Okays Topiramate ER (Qudexy) Monotherapy in Children

Once-a-day capsules are now approved as initial monotherapy for children aged 2 years and up with partial-onset seizures or primary generalized tonic-clonic seizures. FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news